Press release
Thyroid Eye Disease Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharma
DelveInsight's "Thyroid Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Thyroid Eye Disease, historical and forecasted epidemiology as well as the Thyroid Eye Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Thyroid Eye Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Thyroid Eye Disease Market Forecast [https://www.delveinsight.com/sample-request/thyroid-eye-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Thyroid Eye Disease Market Report:
*
The Thyroid Eye Disease market size was valued ~USD 1,993 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In December 2024, Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company dedicated to developing best-in-class therapies for rare and serious conditions, has reported positive topline results from its Phase 3 THRIVE-2 clinical trial. The study evaluated veligrotug (veli), an intravenous (IV) anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, in patients with chronic thyroid eye disease (TED). TED is an autoimmune disorder marked by inflammation, tissue expansion, and damage in the areas surrounding and behind the eyes.
*
In 2022, the United States held the largest market share for Thyroid Eye Disease among the 7MM, with a valuation of around USD 1.98 billion. This figure is projected to grow further by 2034.
*
Among the pipeline therapies, three notable drugs-Viridian Therapeutics' VRDN-001, Immunovant Sciences' batoclimab, and Novartis' COSENTYX (secukinumab)-are poised to make a substantial impact on expanding the Thyroid Eye Disease market.
*
In 2022, the United States reported approximately 1,012,000 prevalent cases of thyroid eye disease.
*
In 2022, the United States represented the largest share of thyroid eye disease cases, comprising approximately 42% of the total population across the 7MM. Germany contributed around 13%, while Japan accounted for about 8% of the total population share.
*
In 2022, Germany had the highest number of thyroid eye disease cases among the EU4 countries, followed by France, while Spain recorded the fewest cases.
*
DelveInsight estimates that in 2022, Japan had approximately 16,300 cases of acute Thyroid Eye Disease and 41,900 cases of chronic Thyroid Eye Disease. These numbers are expected to rise over the forecast period.
*
Key Thyroid Eye Disease Companies: Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharmaceuticals, ValenzaBio, ACELYRIN Inc., Horizon Therapeutics USA, Inc., Neothetics, Inc, Sling Therapeutics, Inc., Novartis, and others
*
Key Thyroid Eye Disease Therapies: Batoclimab (IMVT 1401), COSENTYX (secukinumab), VRDN-001, Linsitinib, Aflibercept, VB421, RVT-140, lonigutamab, Teprotumumab, LIPO-102, Linsitinib, CFZ533, and others
*
The Thyroid Eye Disease epidemiology based on gender analyzed that the incidence of Thyroid Eye Disease is 16 per 100,000 females and 2.9 per 100,000 males with an approximate prevalence of 0.25% with no significant ethnic predisposition
*
The Thyroid Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Thyroid Eye Disease pipeline products will significantly revolutionize the Thyroid Eye Disease market dynamics.
Thyroid Eye Disease Overview
A complex orbital inflammatory condition that can be sight-threatening, incapacitating, and disfiguring is known as thyroid eye disease (TED). In honour of Robert J. Graves, an Irish doctor who first identified thyrotoxicosis in a woman presenting with goitre, rapid heartbeat, and exophthalmos, TED is also known as Graves' ophthalmopathy.
Get a Free sample for the Thyroid Eye Disease Market Report
https://www.delveinsight.com/report-store/thyroid-eye-disease-market [https://www.delveinsight.com/report-store/thyroid-eye-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Thyroid Eye Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Thyroid Eye Disease Epidemiology Segmentation:
The Thyroid Eye Disease market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Thyroid Eye Disease
*
Prevalent Cases of Thyroid Eye Disease by severity
*
Gender-specific Prevalence of Thyroid Eye Disease
*
Diagnosed Cases of Episodic and Chronic Thyroid Eye Disease
Download the report to understand which factors are driving Thyroid Eye Disease epidemiology trends @ Thyroid Eye Disease Epidemiology Forecast [https://www.delveinsight.com/sample-request/thyroid-eye-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Thyroid Eye Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Thyroid Eye Disease market or expected to get launched during the study period. The analysis covers Thyroid Eye Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Thyroid Eye Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Thyroid Eye Disease Therapies and Key Companies
*
Batoclimab (IMVT 1401): Immunovant Sciences
*
COSENTYX (secukinumab): Novartis
*
VRDN-001: Viridian Therapeutics
*
Linsitinib: Sling Therapeutics
*
Aflibercept: Regeneron Pharmaceuticals
*
VB421: ValenzaBio
*
Secukinumab: Novartis
*
RVT-1401: Immunovant Sciences GmbH
*
lonigutamab: ACELYRIN Inc.
*
Teprotumumab: Horizon Therapeutics USA, Inc.
*
LIPO-102: Neothetics, Inc
*
Linsitinib: Sling Therapeutics, Inc.
*
CFZ533: Novartis
Discover more about therapies set to grab major Thyroid Eye Disease market share @ Thyroid Eye Disease Treatment Market [https://www.delveinsight.com/sample-request/thyroid-eye-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Scope of the Thyroid Eye Disease Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Thyroid Eye Disease Companies: Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharmaceuticals, ValenzaBio, ACELYRIN Inc., Horizon Therapeutics USA, Inc., Neothetics, Inc, Sling Therapeutics, Inc., Novartis, and others
*
Key Thyroid Eye Disease Therapies: Batoclimab (IMVT 1401), COSENTYX (secukinumab), VRDN-001, Linsitinib, Aflibercept, VB421, RVT-140, lonigutamab, Teprotumumab, LIPO-102, Linsitinib, CFZ533, and others
*
Thyroid Eye Disease Therapeutic Assessment: Thyroid Eye Disease current marketed and Thyroid Eye Disease emerging therapies
*
Thyroid Eye Disease Market Dynamics: Thyroid Eye Disease market drivers and Thyroid Eye Disease market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Thyroid Eye Disease Unmet Needs, KOL's views, Analyst's views, Thyroid Eye Disease Market Access and Reimbursement
To know more about Thyroid Eye Disease companies working in the treatment market, visit @ Thyroid Eye Disease Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/thyroid-eye-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Thyroid Eye Disease Market Report Introduction
2. Executive Summary for Thyroid Eye Disease
3. SWOT analysis of Thyroid Eye Disease
4. Thyroid Eye Disease Patient Share (%) Overview at a Glance
5. Thyroid Eye Disease Market Overview at a Glance
6. Thyroid Eye Disease Disease Background and Overview
7. Thyroid Eye Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Thyroid Eye Disease
9. Thyroid Eye Disease Current Treatment and Medical Practices
10. Thyroid Eye Disease Unmet Needs
11. Thyroid Eye Disease Emerging Therapies
12. Thyroid Eye Disease Market Outlook
13. Country-Wise Thyroid Eye Disease Market Analysis (2020-2034)
14. Thyroid Eye Disease Market Access and Reimbursement of Therapies
15. Thyroid Eye Disease Market Drivers
16. Thyroid Eye Disease Market Barriers
17. Thyroid Eye Disease Appendix
18. Thyroid Eye Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=thyroid-eye-disease-market-predicted-to-see-upsurge-through-2034-highlights-delveinsight-immunovant-sciences-novartis-viridian-therapeutics-sling-therapeutics-regeneron-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thyroid Eye Disease Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Immunovant Sciences, Novartis, Viridian Therapeutics, Sling Therapeutics, Regeneron Pharma here
News-ID: 3972169 • Views: …
More Releases from ABNewswire
Is Couples Therapy Right? Signs It's Time to See a Counsellor in Birmingham
Relationships can be both fulfilling and challenging. No matter how strong a couple may seem on the outside, it's natural to face hurdles along the way. Miscommunication, stress, life changes, or unresolved issues can create distance between partners. While every couple goes through ups and downs, knowing when to seek professional support can make all the difference. If you've ever found yourself searching for "couples therapy near me" or wondering…
Rialto-Based Get it from Bo Pioneers Collaborative E-Commerce Model Supporting M …
Get it from Bo revolutionizes online retail through strategic manufacturer partnerships that deliver quality products at reasonable prices. The California-based platform, established in 2024, creates sustainable business relationships while expanding inventory daily to serve diverse consumer needs.
Get it from Bo is establishing new standards in the e-commerce industry through its innovative collaborative approach that prioritizes sustainable partnerships with manufacturers and brands while delivering exceptional value to consumers. The Rialto, California-based…
Daily Vibe Launches Comprehensive Fitness Products Store for Diverse Consumer Ma …
New fitness retailer Daily Vibe enters the market with targeted product selections designed to support active lifestyles across multiple demographics. The startup focuses on serving fitness enthusiasts, health-conscious consumers, and older adults seeking quality fitness products.
Founded by Ja'von L. Watson and Joyleena S. Watson, AGAIT International is a fast-growing Atlanta-based tech company dedicated to solving social and economic challenges through creative business and digital solutions. The company develops and manages…
Prolift Handling Brings Advanced pewag Lifting Technology to Ireland
Prolift Handling launches pewag levo Balancer and levo Compensator in Ireland - two advanced lifting solutions that improve safety and precision in heavy lifting operations through remote-controlled positioning and automatic load balancing.
Dublin, Ireland - Sep 30, 2025 - Prolift Handling, Ireland's exclusive pewag partner, today launched two advanced lifting solutions designed to tackle the industry's most challenging safety and precision requirements: the pewag levo Balancer and pewag levo Compensator.
The pewag…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
